RxDoctor Payments Data

Aaron Shemenski, DPM

Foot & Ankle Surgery · Pawtucket, RINPI 1750568374

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,080 of the $7,490 with a category attached, or 67.8%. 30 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 47.9% of the total. Reporting peaked in 2023 at $2,478 and has fallen 84.0% since, to $396 in 2025.

$7,490in general payments, 2019–2025

Across 148 payments — averaging $50.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$4K
  • Smith+Nephew$1K
  • Celularity Inc.$532
  • Zimmer Biomet$246
  • Biotissue Holdings Inc.$224
  • International Life Sciences$181
  • plus $2K from 24 others

What the payments were for

  • Travel & lodging$2,41032%
  • Food & beverage$5,08068%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,490 in reported general payments places this provider in the 75th percentile of 58 foot & ankle surgery providers in Rhode Island.

See all foot & ankle surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$243,259
Medicare patients
863
Services billed
3,991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate24$775
Clotrimazole39$670
Terbinafine Hcl26$289
Oxycodone Hcl23$130

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Pawtucket

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →